India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
How does obesity cause heart disease? Is there a connection between obesity and heart disease? Many people are asking us. As obesity increases, the risk of heart disease may also increase. Obesity is also a cause of diabetes, cholesterol and high blood pressure. A type of fat called 'triglycerides' is high in obese people and the amount of bad cholesterol is also high. Due to all these things, the possibility of blockage of the blood vessels of the heart and blood vessels leading to the brain increases due to long-term accumulation of fat in the blood vessels of the heart and blood vessels leading to the brain. In addition, the possibility of the body's blood vessels being closed increases. Due to this, serious problems like heart attack and stroke start appearing. How do you know that obesity has heart problems? The most common problem in heart disease due to obesity and various other causes is heart artery blockage. In this problem, the amount of cholesterol in the body i...